高级检索
当前位置: 首页 > 详情页

Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion.

文献详情

资源类型:
Pubmed体系:
机构: [1]Center for Core Facility and Advanced Technologies, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China [2]Department of Oncology, Guizhou People’s Hospital, Guizhou 550002, China [3]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China [4]State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China
出处:

摘要:
Guanylate-binding protein 2 (GBP2) is a member of the large GTPase superfamily that is strongly induced by interferon-γ (IFN-γ). Although the biochemical characteristics of GBP2 have been reported in detail, its biological function has not been thoroughly elucidated to date. To the best of our knowledge, this study presents the first demonstration that GBP2 inhibits mitochondrial fission and cell metastasis in breast cancer cells both in vitro and in vivo. Our previous work demonstrated that dynamin-related protein 1 (Drp1)-dependent mitochondrial fission has a key role in breast cancer cell invasion. In this study, we demonstrate that GBP2 binds directly to Drp1. Elimination of Drp1 by shRNA or Mdivi-1 (a Drp1-specific inhibitor) suppressed GBP2's regulatory function. Furthermore, GBP2 blocks Drp1 translocation from the cytosol to mitochondria, thereby attenuating Drp1-dependent mitochondrial fission and breast cancer cell invasion. In summary, our data provide new insights into the function and molecular mechanisms underlying GBP2's regulation of breast cancer cell invasion.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 生物
小类 | 3 区 细胞生物学
最新[2023]版:
大类 | 1 区 生物学
小类 | 2 区 细胞生物学
第一作者:
第一作者机构: [1]Center for Core Facility and Advanced Technologies, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China [*1]Center for Core Facility and Advanced Technologies, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China
共同第一作者:
通讯作者:
通讯机构: [1]Center for Core Facility and Advanced Technologies, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China [3]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China [*1]Center for Core Facility and Advanced Technologies, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China [*2]State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, Sichuan University, 17# People’s South Road, Chengdu, Sichuan Province 610041, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46861 今日访问量:0 总访问量:3333 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号